发明申请
- 专利标题: NOVEL METHOD
-
申请号: US17785036申请日: 2020-12-11
-
公开(公告)号: US20230118721A1公开(公告)日: 2023-04-20
- 发明人: Lieneke Pool , Pavlos Englezou , Maria Wigren , Hanne Romedahl
- 申请人: Idogen AB
- 申请人地址: SE Lund
- 专利权人: Idogen AB
- 当前专利权人: Idogen AB
- 当前专利权人地址: SE Lund
- 优先权: GB1918364.9 20191213
- 国际申请: PCT/EP2020/085857 WO 20201211
- 主分类号: C12N5/0784
- IPC分类号: C12N5/0784 ; A61P37/06 ; A61K35/15 ; A61K39/00
摘要:
There is provided inter alia according to the invention an ex vivo method of obtaining tolerogenic antigen presenting cells (APCs) that have the capability to induce tolerance in the immune system to an antigen, the method comprising (a) isolating monocytes from a sample obtained from a mammal; and (b) culturing the isolated monocytes in a cell culture to induce differentiation of the monocytes into antigen presenting cells having a tolerogenic phenotype, wherein the cell culture comprises (i) retinoic acid and TGFbeta, (ii) retinoic acid, TGFbeta and an AhR agonist or (iii) retinoic acid and an AhR agonist.
信息查询